1. Collen, D. & Haber, E. in Molecular Basis of Cardiovascular Disease (ed. Chien, K.R.) 537–565 (W. B. Saunders., Cambridge, Massachusetts, 1999).
2. Ruggeri, Z.M., Fitzgerald, G.A. & Shattil, S.J. in Molecular Basis of Cardiovascular Disease, (ed. Chien K.R.) 566–589 (W. B. Saunders, Cambridge, Massachusetts, 1999).
3. Heymans, S., et al. Inhibition of plasminogen activators or matrix metalloproteinases prevents cardiac rupture but impairs therapeutic angiogenesis and causes cardiac failure after myocardial infarction. Nature Med. 5, 1135–1142 (1999).
4. Moulton, K.S. & Folkman, J. in Molecular basis of cardiovascular disease (ed. Chien, K.R.) 393–409 (W. B. Saunders Co., Cambridge, Massachusetts, 1999).
5. Chien, K.R. Stress Pathways and Heart Failure. Cell 98, 555–558 (1999).